Anti-RNA polymerase III systemic sclerosis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Diffuse cutaneous systemic sclerosis
Diffuse cutaneous systemic sclerosis is the single best answer because anti-RNA polymerase III predicts diffuse systemic sclerosis and renal crisis risk. The stem is testing diagnostic synthesis, not isolated recall, so the relevant clinical pattern and risk context determine the answer. Rheumatoid arthritis is less suitable because it fits a different clinical pattern or a different treatment threshold; Systemic lupus erythematosus, Psoriatic arthritis and Gout do not address the key discriminator in this vignette. Clinical pearl: in SCE-style rheumatology questions, autoantibodies, imaging and synovial fluid findings should be interpreted with the whole phenotype.
Reference: BSR hot swollen joint guidance; EULAR imaging/autoantibody recommendations